Humanwell Healthcare Group Co Ltd (600079) - Total Liabilities

Latest as of June 2025: CN¥16.15 Billion CNY ≈ $2.36 Billion USD

Based on the latest financial reports, Humanwell Healthcare Group Co Ltd (600079) has total liabilities worth CN¥16.15 Billion CNY (≈ $2.36 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Humanwell Healthcare Group Co Ltd growing its equity to track the company's year-over-year net asset growth rate.

Humanwell Healthcare Group Co Ltd - Total Liabilities Trend (2000–2024)

This chart illustrates how Humanwell Healthcare Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 600079 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Humanwell Healthcare Group Co Ltd Competitors by Total Liabilities

The table below lists competitors of Humanwell Healthcare Group Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Methanex Corporation
TO:MX
Canada CA$4.51 Billion
MiniMed Group, Inc. Common Stock
NASDAQ:MMED
USA $1.02 Billion
Whitehaven Coal Ltd
AU:WHC
Australia AU$6.12 Billion
HLA GROUP CORP LTD
SHG:600398
China CN¥14.02 Billion
Magnolia Oil & Gas Corp
NYSE:MGY
USA $917.17 Million
BICECORP S.A
SN:BICECORP
Chile CL$32.65 Trillion
Etablissementen Franz Colruyt NV
BR:COLR
Belgium €3.22 Billion
Jiangsu Aucksun Co Ltd
SHE:002245
China CN¥5.12 Billion

Liability Composition Analysis (2000–2024)

This chart breaks down Humanwell Healthcare Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Humanwell Healthcare Group Co Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.54 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.88 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.43 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Humanwell Healthcare Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Humanwell Healthcare Group Co Ltd (2000–2024)

The table below shows the annual total liabilities of Humanwell Healthcare Group Co Ltd from 2000 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥15.82 Billion
≈ $2.31 Billion
-1.80%
2023-12-31 CN¥16.11 Billion
≈ $2.36 Billion
-10.92%
2022-12-31 CN¥18.08 Billion
≈ $2.65 Billion
-4.09%
2021-12-31 CN¥18.85 Billion
≈ $2.76 Billion
+0.86%
2020-12-31 CN¥18.69 Billion
≈ $2.73 Billion
-11.07%
2019-12-31 CN¥21.02 Billion
≈ $3.08 Billion
-0.64%
2018-12-31 CN¥21.15 Billion
≈ $3.10 Billion
+12.51%
2017-12-31 CN¥18.80 Billion
≈ $2.75 Billion
+30.15%
2016-12-31 CN¥14.45 Billion
≈ $2.11 Billion
+61.04%
2015-12-31 CN¥8.97 Billion
≈ $1.31 Billion
+39.30%
2014-12-31 CN¥6.44 Billion
≈ $942.28 Million
+39.18%
2013-12-31 CN¥4.63 Billion
≈ $677.03 Million
+9.85%
2012-12-31 CN¥4.21 Billion
≈ $616.30 Million
+38.93%
2011-12-31 CN¥3.03 Billion
≈ $443.59 Million
+59.49%
2010-12-31 CN¥1.90 Billion
≈ $278.12 Million
+54.87%
2009-12-31 CN¥1.23 Billion
≈ $179.58 Million
-6.61%
2008-12-31 CN¥1.31 Billion
≈ $192.30 Million
+5.13%
2007-12-31 CN¥1.25 Billion
≈ $182.91 Million
+4.88%
2006-12-31 CN¥1.19 Billion
≈ $174.41 Million
-6.60%
2005-12-31 CN¥1.28 Billion
≈ $186.72 Million
+15.97%
2004-12-31 CN¥1.10 Billion
≈ $161.00 Million
+9.51%
2003-12-31 CN¥1.00 Billion
≈ $147.02 Million
+34.99%
2002-12-31 CN¥744.27 Million
≈ $108.91 Million
+25.15%
2001-12-31 CN¥594.72 Million
≈ $87.03 Million
+208.11%
2000-12-31 CN¥193.03 Million
≈ $28.25 Million
--

About Humanwell Healthcare Group Co Ltd

SHG:600079 China Drug Manufacturers - Specialty & Generic
Market Cap
$4.25 Billion
CN¥29.07 Billion CNY
Market Cap Rank
#3962 Global
#583 in China
Share Price
CN¥17.81
Change (1 day)
+0.74%
52-Week Range
CN¥16.37 - CN¥23.03
All Time High
CN¥37.30
About

Humanwell Healthcare (Group) Co.,Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers sufentanil citrate injection, an analgesic drug for combined anesthesia; remifentanil hydrochloride injection for induction of general anesthesia and maintenance of analgesia during general anesthesia; hydromorphone hydrochloride injection for pa… Read more